The Taxotere (docetaxel) MDL contains 12,471 separate cases and a total of 15,568 claims. The majority of the cases seek punitive damages for alopecia. This article will explain how this multidistrict litigation was formed. The MDL is a legal method of combining similar claims in one lawsuit. The goal is to ensure maximum compensation to the victims of this drug.
Taxotere (docetaxel) MDL is a multidistrict litigation
The Judicial Panel on Multidistrict Litigation has approved the creation of a Taxotere Multidistrict Litigation docket. It now consists of six actions pending in four districts. As of March 16, Taxotere was approved by the U.S. Food and Drug Administration to treat breast cancer. But the drug has since been approved to treat non-small cell lung, stomach, neck, and prostate cancer. Because of its serious side effects, the FDA issued Black Box warnings. These warnings included the risks of anaphylaxis, kidney damage, and low blood pressure. Some cases have been permanently lost to the drug.
According to the Taxotere MDL, over 12,000 federal lawsuits were filed against the drug makers. Some lawsuits allege that the drug manufacturer was negligent in failing to warn patients about permanent hair loss caused by Taxotere. Currently, there are no settlements in this case. But the litigation will take a long time. For now, the plaintiffs have filed an appeal.
It has 12,471 pending cases
Approximately a third of all pending cases in the United States involves the prescription drug Taxotere. This resurgence in the number of cases is attributed to the ongoing public health measures against the drug. There are currently twelve million Americans who take Taxotere. However, not everyone takes the drug. A large majority of Americans do not. This makes the drug’s continued use by millions of Americans all the more dangerous.
The Taxotere MDL is one of the largest drug lawsuits, with approximately twelve thousand total cases. Since October 2016, the MDL has grown dramatically, from just a few dozen cases to more than twelve thousand. The drug’s widespread use and the associated risk of permanent hair loss have increased the number of lawsuits filed. Although the Taxotere MDL is relatively small, it is expected to continue to grow.
It has contained a total of 15,568 different cases
The MDL filed against Sanofi over the cancer drug Taxotere contains a total of 15,568 different cases. As of November 21, the plaintiffs and defendants of the Taxotere lawsuits have filed their preliminary witness lists with the court. In November, three defendants – Sandoz, Inc., Hospira, Inc., and Accord Healthcare – filed their preliminary witness lists in the Taxotere MDL.
The Taxotere MDL was first filed in October 2016. The number of cases increased in September 2018. In the Eastern District of Louisiana, a jury found in favor of Sanofi. The trial involved thousands of plaintiffs alleging that Sanofi failed to warn patients of the potential for permanent hair loss. The trial was conducted before US District Judge Jane Triche Milazzo.
Plaintiffs in Taxotere lawsuits claim that the cancer drug caused permanent hair loss. Because Taxotere is used to treat breast cancer, the drug’s label should have warned patients that permanent hair loss is possible. However, plaintiffs claim that Sanofi failed to adequately warn patients about permanent hair loss from the drug. While plaintiffs’ cases typically take years to litigate their cases, it is crucial to be patient-centered and have a plan to deal with the lengthy litigation.
It seeks punitive damages for alopecia
A recent class action lawsuit filed by victims of Taxotere for permanent hair loss alleges that the drug caused irreversible alopecia and is responsible for the loss of their tresses. While the FDA approved Taxotere for the treatment of breast cancer in 1996, it didn’t warn users that permanent alopecia was possible. The company’s warning materials failed to include the word “permanent” and the warning of permanent hair loss didn’t come until 2015.
The class action suit was filed on behalf of hundreds to thousands of people who have been harmed by Taxotere. The cases have been consolidated into a Multi-District Litigation (MDL), which streamlines pretrial activities for multiple cases in a single court. This type of litigation is typically less expensive for everyone involved. Additionally, the cost of hiring a quality attorney for a class action case is typically split by all parties.